CATHERINE COLLIER: Open Payments
NPI 1932569977 · FRAMINGHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,264 in 81 payments from 8 companies in 2025. Trend: 2023 $631 · 2024 $1,391 · 2025 $2,264
Food & beverage: $2,230Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 47 | $1,516 |
| Regeneron Healthcare Solutions, Inc. | 12 | $323 |
| GENZYME CORPORATION | 13 | $220 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| INOGEN, INC. | 1 | $35 |
| Amgen Inc. | 1 | $34 |
| Insmed, Inc. | 2 | $33 |
| Viatris Specialty LLC | 1 | $23 |
Products named: DUPIXENT, AIRSUPRA, FASENRA, BREZTRI, TEZSPIRE, NUCALA, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, Arikayce.
Industry payments across MA — which companies pay providers there.
